Launxp Biomedical Co (6876.TWO) Stock Price
Launxp Biomedical Co Price
Revenue has compounded at 32.7% per year over the past 4 years to 2.48 M TWD. Launxp Biomedical Co's net margin stands at -3,325.1%, up from -3,594.6% several years earlier.
Launxp Biomedical Co stock price
Launxp Biomedical Co business model & stock analysis
Frequently asked questions about Launxp Biomedical Co
Converted at the current exchange rate, the Launxp Biomedical Co share trades at 0.42 EUR (15.20 TWD).
The revenue cannot currently be calculated for Launxp Biomedical Co.
The profit cannot currently be calculated for Launxp Biomedical Co.
The P/E ratio cannot be calculated for Launxp Biomedical Co at the moment.
The P/S cannot be calculated for Launxp Biomedical Co currently.
The Eulerpool Quality Score for Launxp Biomedical Co is 3/10.
The ISIN of Launxp Biomedical Co is TW0006876006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Launxp Biomedical Co is 6876.TWO. The ticker symbol is used to trade Launxp Biomedical Co shares on the stock exchange.
Launxp Biomedical Co stock
Launxp Biomedical Co Peer Group
All fundamentals and in-depth analysis of Launxp Biomedical Co
Our stock analysis for Launxp Biomedical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Launxp Biomedical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.